MEPROlife is a Medtech company whose mission is to make the dream of many couples of achieving parenthood come true by developing personalized solutions for male infertility. MEPROlife is developing a more precise human sperm selection methodology able to select spermatozoa with the greatest fertilizing capacity, which increases the effectiveness of the assistant reproductive treatments without significantly increasing the overall cost of the treatment. Our technology will reduce the number of couples undergoing assisted reproductive treatments that fail to achieve pregnancy.